However, increasing the levels of glutathione may give numerous health benefits
It was released as a blood glucose control treatment for patients with diabetes, but it was approved for use as an obesity treatment by the US Food and Drug Administration (FDA) in 2014, as it was found to be effective for weight loss without hypoglycemia in obese people who did not have diabetes
Journal of Toxicology 2011, 152474: 1-16
However, in patients who develop chronic conditions, this oxidative fire is never successfully extinguished, leading to sustained collateral damage to the hosts own tissues
It exploits the legitimate scientific achievements of researchers who spent careers developing these medications
Clinicians avoid prescribing GLP-1 agonists for individuals with a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2A (MEN 2A), or type 2B (MEN 2B) (51)(53)